Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 16.08 Delayed Data As of 4:00pm ET |  -0.65 / -3.89%Today’s Change | 11.70 Today|||52-Week Range 48.75 | -56.55% Year-to-Date |
Latest ARCT News | Press Releases
No recent news for Arcturus Therapeutics Holdings Inc.
Today’s Trading
| Previous close | 16.73 |
| Today’s open | 16.44 |
| Day’s range | 15.43 - 16.58 |
| Volume | 32,673 |
| Average volume (3 months) | 546,956 |
| Market cap | $392.5M |
Data as of 4:00pm ET, 10/05/2022
Growth & Valuation
| Earnings growth (last year) | -117.81% |
| Earnings growth (this year) | +19.12% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +29.56% |
| P/E ratio | NM |
| Price/Sales | 78.81 |
| Price/Book | 1.71 |
Competitors
Data as of 4:00pm ET, 10/05/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$1.81 |
| Annual revenue (last year) | $12.4M |
| Annual profit (last year) | -$203.7M |
| Net profit margin | -1,647.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
